James M. Pellissier

Statistics

Publications

Citations

H-Index

Active since

1991

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Northwestern University

United States Military Academy

Health Outcomes Solutions (United States)

Loyola University Chicago

James M. Pellissier is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in cost-effectiveness analysis, pharmacoeconomics, and cost-effectiveness modeling.

Publications per year

1991–2019

Publications

The incidence of herpes zoster in a United States administrative database

Ralph P. Insinga, Robbin Itzler, James M. Pellissier et al. · Journal of General Internal Medicine · 2005 · 491 citations

Veterinary Medicine, Infectious Disease Control, Infectious Diseases +10

Cost Effectiveness of Anterior Cruciate Ligament Reconstruction in Young Adults

Charles A. Gottlob, Champ L. Baker, James M. Pellissier et al. · Clinical Orthopaedics and Related Research · 1999 · 225 citations

Pharmacy, Orthopaedic Surgery, Surgery +17

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States

Min Huang, Yanyan Lou, James M. Pellissier et al. · PharmacoEconomics · 2017 · 152 citations · Full text

Medicine, Oncology, Pharmacoeconomics +15

Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults

James M. Pellissier, Marc Brisson, Myron J. Levin · Vaccine · 2007 · 143 citations

Veterinary Medicine, Infectious Diseases, Pharmacoeconomics +16

Health Care Utilization and Cost Burden of Herpes Zoster in a Community Population

Barbara P. Yawn, Robbin Itzler, Peter C. Wollan et al. · Mayo Clinic Proceedings · 2009 · 113 citations · Full text

Public Affairs, Infectious Diseases, Pharmacoeconomics +11

1–5 of 35